GlassScriptPhysician profile
William A Yelle
NPI 1013007319
$4,564.26
in general payments reported to CMS, 2019-2025
16 companies · $716 in 2025
The $716 reported for 2025 was more than what 93% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $22.80 · 2022: $514 · 2023: $1,754 · 2024: $1,559 · 2025: $716.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,028.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,027.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,092.86 | 2022-2024 | Skyrizi, Rinvoq |
| Takeda Pharmaceuticals U.S.A., INC. | $827.39 | 2022-2025 | Entyvio, Eohilia, Gattex |
| Janssen Biotech, INC. | $574.16 | 2020-2025 | Tremfya, Stelara, Remicade |
| Ardelyx, INC. | $417.17 | 2023-2025 | Ibsrela |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $348.51 | 2023 | Xifaxan, Trulance |
| Genzyme Corporation | $274.52 | 2023-2024 | |
| Lilly USA, LLC | $199.45 | 2024-2025 | Omvoh |
| Phathom Pharmaceuticals, INC. | $164.43 | 2024-2025 | Voquezna |
| Celgene Corporation | $161.74 | 2022-2023 | Zeposia |
| Gilead Sciences, INC. | $136.41 | 2023-2025 | Epclusa |
| Organon LLC | $106.50 | 2023-2024 | Hadlima, Renflexis |
| Intercept Pharmaceuticals, INC. | $102.80 | 2024-2025 | |
| Ironwood Pharmaceuticals, INC | $61.15 | 2022-2024 | Linzess |
| Nestle Healthcare Nutrition INC. | $49.06 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $33.86 | 2024 | Dupixent |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fresenius Kabi USA, LLC | $14.25 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Yelle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.